Replies to post #50477 on Amarantus Bioscience Holdings Inc (AMBS)

[zoomboom]

AMBS having patents on 47 Protein Biomarkers for Neurodegenerative Diseases including PD. you can see the connection right?


With the acquisition of these assets, Amarantus added following issued patents to its portfolio:

12/802,630 – Diagnosis of Parkinson’s Disease
13/118,175 – Assays for diagnosis and therapeutics…ALS and Parkinson’s Disease
12/069,807 – 47 Protein Biomarkers for Neurodegenerative Diseases
12/804,868 – Assays for Amyotrophic Lateral Sclerosis (ALS) and ALS-like disorders
13/153,669 – Diagnosis of Alzheimer’s Disease

http://www.redorbit.com/news/health/1112754065/amarantus-bioscience-acquires-neurodegenerative-diagnostic-intellectual-property-portfolio-from-power3/

[~S.B.A.~]

<<AMBS>>WOW MUST READ!
In at .0086. Longs have locked the float. Charts moving side ways now. On radar!

BTW:"The buzz on Wall Street surrounding Amarantus is the grant from the Michael J. Fox Foundation for Parkinson's Research. This money funded a pre-clinical experiment that confirmed what was previously reported in the Journal of Neuroscience in 2009 - that MANF significantly reduces the behavioral deficits caused by the neurotoxin 6-OHDA in a standard animal model of Parkinson's disease"
source: http://ih.advfn.com/p.php?pid=nmona&article=49934989

Never underestimate...